BR9911072A - Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior - Google Patents

Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior

Info

Publication number
BR9911072A
BR9911072A BR9911072-5A BR9911072A BR9911072A BR 9911072 A BR9911072 A BR 9911072A BR 9911072 A BR9911072 A BR 9911072A BR 9911072 A BR9911072 A BR 9911072A
Authority
BR
Brazil
Prior art keywords
agents
respiratory tract
lower respiratory
preparations
application
Prior art date
Application number
BR9911072-5A
Other languages
English (en)
Inventor
Wolfgang Fleischer
Karen Reimer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of BR9911072A publication Critical patent/BR9911072A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Patente de Invenção: <B>"PREPARAçõES PARA APLICAçãO DE AGENTES ANTIINFLAMATóRIOS, ESPECIALMENTE ANTI-SéPTICOS E/OU AGENTES PROMOTORES DA CURA DE FERIDAS NO TRATO RESPIRATóRIO INFERIOR"<D>. A presente invenção refere-se ao uso de agentes antiinflamatórios, tal como iodo povidona, para a preparação de uma composição farmacêutica para o tratamento de doenças de trato respiratório inferior, que são suscetíveis à administração de tais agentes.
BR9911072-5A 1998-05-27 1999-05-27 Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior BR9911072A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8689598P 1998-05-27 1998-05-27
PCT/EP1999/003681 WO1999060999A1 (en) 1998-05-27 1999-05-27 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract

Publications (1)

Publication Number Publication Date
BR9911072A true BR9911072A (pt) 2001-02-06

Family

ID=22201600

Family Applications (3)

Application Number Title Priority Date Filing Date
BR9911071-7A BR9911071A (pt) 1998-05-27 1999-05-27 Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
BR9911072-5A BR9911072A (pt) 1998-05-27 1999-05-27 Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
BR9911070-9A BR9911070A (pt) 1998-05-27 1999-05-27 Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9911071-7A BR9911071A (pt) 1998-05-27 1999-05-27 Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR9911070-9A BR9911070A (pt) 1998-05-27 1999-05-27 Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto

Country Status (19)

Country Link
US (2) US20080038330A1 (pt)
EP (3) EP1083886B1 (pt)
JP (3) JP2002516269A (pt)
KR (3) KR20010043820A (pt)
CN (3) CN1303272A (pt)
AT (3) ATE319427T1 (pt)
AU (3) AU759264B2 (pt)
BR (3) BR9911071A (pt)
CA (3) CA2332389C (pt)
CY (1) CY1105834T1 (pt)
DE (6) DE29923848U1 (pt)
DK (2) DK1079807T3 (pt)
ES (2) ES2260915T3 (pt)
HK (2) HK1035335A1 (pt)
HU (3) HU226729B1 (pt)
IL (4) IL139229A0 (pt)
PT (2) PT1079806E (pt)
RU (3) RU2211693C2 (pt)
WO (3) WO1999060999A1 (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE458471T1 (de) * 1999-05-27 2010-03-15 Euro Celtique Sa Formulierungen mit povidon-iod zur behandlung von wunden
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
EP1502586B1 (en) * 1999-05-27 2006-09-27 Euro-Celtique S.A. Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body
ES2539904T3 (es) * 2000-02-08 2015-07-07 Euro-Celtique S.A. Formulaciones orales de agonistas opioides resistentes a manipulaciones indebidas
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
WO2002054868A2 (en) 2000-12-21 2002-07-18 Inhale Therapeutic Syst Pulmonary delivery of polyene antifungal agents
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
CA2477592A1 (en) * 2002-03-18 2003-09-25 Yamanouchi Pharmaceutical Co., Ltd. Powdery medicinal compositions for inhalation and process for producing the same
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
JP4391948B2 (ja) * 2002-11-11 2009-12-24 興和株式会社 損傷皮膚修復用組成物
CA2549994A1 (en) * 2002-12-18 2004-08-12 Hough Ear Institute Otologic nanotechnology
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes
DK1479379T3 (da) * 2003-05-19 2008-01-02 Euro Celtique Sa Törre, liposomale PVP-iod-sammensætninger
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
EP2497460A1 (en) 2005-03-10 2012-09-12 3M Innovative Properties Co. Methods of reducing microbial contamination
US9826770B2 (en) 2005-03-10 2017-11-28 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
DE102006011314A1 (de) 2006-03-11 2007-10-18 Peter Dr. Engels Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze
KR20080105174A (ko) * 2006-04-03 2008-12-03 테바 파마슈티컬 인더스트리즈 리미티드 약물 미립자
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
MX2009004246A (es) 2006-10-27 2009-05-14 3M Innovative Properties Co Composiciones antimicrobianas.
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
EA017359B1 (ru) * 2007-11-23 2012-11-30 Фармалунденсис Аб Способ и композиция для достижения бронхиальной релаксации
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
KR20100048751A (ko) * 2008-10-31 2010-05-11 주식회사 동성바이오레인 스프레이 가능한 캡슐화된 기능성 미립자 조성물과 그 제조방법
NL2002442C2 (nl) 2009-01-22 2010-07-26 Weezenbeek Specialties B V Van Werkwijze voor het verjongen van een bitumen bevattende samenstelling.
EP2226073A1 (en) 2009-03-02 2010-09-08 Euro-Celtique S.A. Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
US20110086084A1 (en) * 2009-10-13 2011-04-14 David William Koenig Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same
RS56687B1 (sr) 2010-12-30 2018-03-30 Aktsionernoye Obshchestvo Nauchnyi Tsentr Protivoinfektsionnyh Preparatov Antibakterijsko sredstvo za tretman infektivnih bolesti bakterijskog porekla
WO2013059622A1 (en) * 2011-10-19 2013-04-25 President And Fellows Of Harvard College Treatments for mycobacterium tuberculosis
KR101860485B1 (ko) * 2011-11-03 2018-07-02 (주)아모레퍼시픽 미세 유화 입자를 포함하는 미용 티슈, 그 제조방법 및 사용방법
PT2852391T (pt) * 2012-05-21 2022-02-18 Insmed Inc Sistemas para tratamento de infeções pulmonares
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
RU2538433C1 (ru) * 2013-06-11 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО ФИРН М") Фармацевтическая композиция для профилактики и лечения инфекционно-воспалительных заболеваний различной этиологии путем оромукозного введения
MX2016005232A (es) 2013-10-22 2017-01-19 Aradigm Corp Formulaciones liposomicas para inhalacion, modificadas con agente tensoactivo, que proveen un perfil de liberacion tanto inmediata como sostenida.
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
JP2017513839A (ja) * 2014-04-08 2017-06-01 アラダイム コーポレーション 凍結融解後に薬物ナノ結晶を形成するリポソーム
CA2943049A1 (en) 2014-04-08 2015-10-15 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
DK3142643T3 (da) 2014-05-15 2019-10-14 Insmed Inc Fremgangsmåder til behandling af ikke-tuberkuløse mykobakterielle lungeinfektioner
WO2016011496A1 (en) 2014-07-23 2016-01-28 Firebrick Pharma Pty Ltd Treatment and prevention of the common cold using povidone-iodine
KR102086150B1 (ko) 2017-04-10 2020-03-06 부산대학교 산학협력단 하이드로겔화 되는 창상 치료용 파우더 조성물 및 이의 제조방법
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
US20200289552A1 (en) * 2017-07-04 2020-09-17 Fluchem Ltd Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
KR101935250B1 (ko) * 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
WO2019009630A1 (ko) * 2017-07-04 2019-01-10 김대황 수용해성이 향상된 요오드제 및 염화나트륨을 포함하는 고체 조성물 및 이의 수용액을 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
KR102026805B1 (ko) 2017-12-12 2019-11-04 주식회사 크로파세 항염 화장료 조성물
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
WO2019202400A1 (en) * 2018-04-17 2019-10-24 Universite De Caen Normandie Bambuterol for the treatment of alzheimer's disease
RU2730834C1 (ru) * 2020-01-17 2020-08-26 Александр Александрович Кролевец Способ получения нанокапсул тимола
WO2021201310A1 (ko) * 2020-03-30 2021-10-07 현대바이오사이언스 주식회사 비타민과 덱스판테놀이 봉입된 에토좀 조성물 및 이의 제조방법
CN111700883B (zh) * 2020-07-23 2021-04-06 深圳大佛药业股份有限公司 一种硫酸沙丁胺醇缓释型吸入制剂及其生产工艺
JP2022151426A (ja) * 2021-03-26 2022-10-07 均 石井 上気道炎治療薬。
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (pt) * 1952-04-15 1900-01-01
US4113857A (en) * 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE3826946C1 (pt) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
EP0407028B2 (en) * 1989-05-31 1999-07-07 FISONS plc Medicament inhalation device and formulation
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5128139A (en) * 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
JP2527107B2 (ja) * 1991-04-16 1996-08-21 日本新薬株式会社 固体分散体の製造方法
DE69232706T2 (de) * 1991-05-01 2002-11-28 Jackson H M Found Military Med Verfahren zur behandlung infektiöser respiratorischer erkrankungen
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) * 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5456904A (en) * 1993-06-28 1995-10-10 The Procter & Gamble Company Photoprotection compositions comprising certain chelating agents
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro Celtique Sa Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
PT789584E (pt) * 1994-11-04 2002-03-28 Polymun Scient Immunbio Forsch Aplicacao de superoxido-dismutase (sod) em liposomas
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
JPH08301774A (ja) * 1995-05-08 1996-11-19 Kowa Co 喉用殺菌消毒薬
AU7454698A (en) * 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
US7297344B1 (en) * 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) * 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
EP1502586B1 (en) * 1999-05-27 2006-09-27 Euro-Celtique S.A. Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body
ATE458471T1 (de) * 1999-05-27 2010-03-15 Euro Celtique Sa Formulierungen mit povidon-iod zur behandlung von wunden
US6497896B2 (en) * 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
DK1479379T3 (da) * 2003-05-19 2008-01-02 Euro Celtique Sa Törre, liposomale PVP-iod-sammensætninger
WO2011008987A2 (en) * 2009-07-15 2011-01-20 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications

Also Published As

Publication number Publication date
PT1079807E (pt) 2007-01-31
ATE235895T1 (de) 2003-04-15
BR9911070A (pt) 2001-02-06
DE69930259D1 (de) 2006-05-04
KR100445146B1 (ko) 2004-08-18
HK1035335A1 (en) 2001-11-23
AU752018C (en) 2003-10-09
KR100613706B1 (ko) 2006-08-21
HUP0102892A3 (en) 2002-12-28
ATE319427T1 (de) 2006-03-15
CA2332369A1 (en) 1999-12-02
AU752018B2 (en) 2002-09-05
PT1079806E (pt) 2006-06-30
EP1079806A1 (en) 2001-03-07
AU747877B2 (en) 2002-05-30
CN1303276A (zh) 2001-07-11
WO1999060998A1 (en) 1999-12-02
EP1079806B1 (en) 2006-03-08
US20120009253A1 (en) 2012-01-12
ES2260915T3 (es) 2006-11-01
CA2332371A1 (en) 1999-12-02
DE29923847U1 (de) 2001-04-12
RU2212884C2 (ru) 2003-09-27
HU226729B1 (en) 2009-08-28
DE69930259T2 (de) 2006-11-23
DK1079806T3 (da) 2006-07-17
HK1035336A1 (en) 2001-11-23
IL139229A0 (en) 2001-11-25
AU4370499A (en) 1999-12-13
IL139231A0 (en) 2001-11-25
IL139230A (en) 2007-07-24
RU2211693C2 (ru) 2003-09-10
DK1079807T3 (da) 2007-01-22
EP1083886A1 (en) 2001-03-21
US20080038330A1 (en) 2008-02-14
CA2332389A1 (en) 1999-12-02
DE69933208T2 (de) 2007-08-30
HUP0102892A2 (hu) 2002-03-28
JP4741727B2 (ja) 2011-08-10
DE69906518D1 (de) 2003-05-08
EP1079807B1 (en) 2006-09-13
ES2273493T3 (es) 2007-05-01
AU4266799A (en) 1999-12-13
WO1999061003A1 (en) 1999-12-02
KR20010043820A (ko) 2001-05-25
WO1999060999A1 (en) 1999-12-02
HU226710B1 (en) 2009-07-28
ATE339187T1 (de) 2006-10-15
JP2002516265A (ja) 2002-06-04
DE69933208D1 (de) 2006-10-26
HUP0102337A2 (hu) 2002-03-28
CN1303272A (zh) 2001-07-11
EP1079807A1 (en) 2001-03-07
BR9911071A (pt) 2001-02-06
HUP0102899A2 (hu) 2002-03-28
RU2202340C2 (ru) 2003-04-20
JP4741726B2 (ja) 2011-08-10
KR20010043819A (ko) 2001-05-25
CA2332389C (en) 2008-09-09
KR20010043821A (ko) 2001-05-25
JP2002516269A (ja) 2002-06-04
CN1303271A (zh) 2001-07-11
AU4370699A (en) 1999-12-13
EP1083886B1 (en) 2003-04-02
IL139230A0 (en) 2001-11-25
AU759264B2 (en) 2003-04-10
HUP0102899A3 (en) 2002-12-28
CY1105834T1 (el) 2011-02-02
DE29923766U1 (de) 2001-06-07
JP2002516266A (ja) 2002-06-04
DE29923848U1 (de) 2001-04-12
HUP0102337A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
BR9911072A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
BR9908488A (pt) Composição farmacêutica de topiramato
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE231852T1 (de) Bicyclische aromatische verbindungen
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
DE60142632D1 (de) Heilung von wunden
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
BR9907234A (pt) Polìmeros ligantes de gordura
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
DE60222662D1 (de) Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
BR0205625C1 (pt) Formulações nasais em gel

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI